Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study Paolo Gallo , Antonio De Vincentis , Valeria Pace Palitti , Maurizio Russello , Anthony Vignone , Domenico Alvaro , Raffaella Tortora , Marco Biolato , Maurizio Pompili , Vincenza Calvaruso , Marzia Veneziano , Marco Tizzani , Francesco Frigo , Alessandro Caneglias , Gesualdo Marcantonio , Alfredo Marzano , Valerio Rosato , Ernesto Claar , Rosanna Villani , Antonio Izzi , Raffaele Cozzolongo , Aldo Airoldi , Chiara Mazzarelli , Marco Distefano , Claudia Iegri , Stefano Fagiuoli , Vincenzo Messina , Enrico Ragone , Rodolfo Sacco , Pierluigi Cacciatore , Flora Masutti , Lory Saveria Croce , Alessandra Moretti , Francesca Terracciani , Andrea Falcomata , Giulia Di Pasquale , Valentina Flagiello , Antonio Picardi , Umberto Vespasiani-Gentilucci Journal of Hepatology（2024）
Key words
severe thrombocytopenia, thrombopoietin receptor agonists (TPO-RA), lusutrombopag, portal vein thrombosis (PVT)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
